Ascendia Pharmaceutical Solutions
661 US Highway One
North Brunswick, NJ 08902
T: (732) 638-4028
E: bd@ascendiaCDMO.com
W: www.ascendiacdmo.com
Ascendia Pharmaceutical Solutions is drug development teams’ fast, flexible, and first time right CDMO partner. It makes the Impossible Possible through a comprehensive suite of pre-formulation, formulation development, cGMP manufacturing, and ICH stability services for a variety of dosage forms and clinical trial materials (CTM), using proprietary enabling nanotechnologies. The company built its success on its customer-centric BEST philosophy (Brilliant technology, Excellent service, Superior quality, and Trust).
Its North Brunswick, NJ 60,000 square-foot facility has Class 10,000 (ISO 7) and Class 100 (ISO 5) cleanrooms, as well as Class 100,000 (ISO 8) manufacturing suites. The CDMO provides custom sterile and non-sterile enabling formulations, along with analytical methods for new chemical entities, complex dosage forms, and 505(B)(2) product development, as well as OTCs, veterinary drugs, and nutraceuticals.
Ascendia Pharmaceutical Solutions delivers sophisticated formulations to enhance bioavailability and solubility using four proprietary nanotechnologies – AmorSol®, EmulSol®, LipidSol®, and NanoSol®.
This combination of technologies, facilities, and expertise is why Ascendia Pharmaceutical Solutions can start projects and Tech-Transfers in its United States facility within two weeks.
Company Description
Strategically located in the heart of the New Jersey Bioscience Center, Ascendia Pharmaceutical Solutions provides advanced U.S.-based CDMO services from discovery to commercialization. It has a proven track record in developing formulations for API screening and CTM, that helps in all phases for fast drug development. A fine mix of proprietary technologies, state-of-the-art manufacturing suites, and a team of formulators and scientists with expertise and knowledge allows Ascendia Pharmaceutical Solutions to solve problems quickly.
Ascendia Pharmaceutical Solutions uses all GRAS (Generally Regarded As Safe) materials, to streamline formulation development that results in time and money savings. Ascendia Pharmaceutical Solutions is a rare U.S.-based CDMO with capabilities that include spray drying, aseptic fill finish, lyophilization, GMP-grade NETZSCH DeltaVita® 600 Gamma Vita equipment, and the Precision Nanosystems NanoAssembler™ Ignite™, NanoAssemblr™ Blaze+™, and NanoAssemblr™ GMP System. These expansive capabilities position it as expert in working with lipid nanoparticles (LNPs) and nanostructured lipid carriers (NLCs), among others.
Company Background
Founded in 2012, Ascendia Pharmaceutical Solutions offers a comprehensive suite of pre-formulation, formulation development, cGMP manufacturing, and ICH stability services for all dosage forms. Ascendia Pharmaceutical Solutions built its foundation of success on its customer-centric culture that exudes its BEST philosophy. This approach has led to Ascendia Pharmaceutical Solutions doubling in size in the past four years and being named to the prestigious Inc. 5000 list four consecutive years.
Markets Served/Facilities
Ascendia Pharmaceutical Solutions is headquartered in the New Jersey Bioscience Center, North Brunswick, NJ. Its 60,000 square-foot facility has Class 10,000 (ISO 7) and Class 100 (ISO 5) cleanrooms, as well as Class 100,000 (ISO 8) manufacturing suites. It provides custom sterile and non-sterile enabling formulations, along with analytical methods for new chemical entities, complex dosage forms, and 505(B)(2) product development, as well as OTCs, veterinary drugs, and nutraceuticals.
The CDMO’s expertise and capabilities allow it to scale-up and optimize various dosage forms. In fact, Ascendia Pharmaceutical Solutions has a proven track record of developing new dosage forms that were previously unattainable. Its successes are why pharmaceutical companies have entrusted Ascendia Pharmaceutical Solutions with tech transfers that lead to cost and time benefits.
Products, Services & Capabilities
Ascendia Pharmaceutical Solutions delivers sophisticated formulations to enhance bioavailability and solubility using four proprietary nanotechnologies – AmorSol®, EmulSol®, LipidSol™, and NanoSol®. Its state-of-the-art facility supports GLP and cGMP manufacturing in accordance with ICH guidelines.
Drug development teams rely on Ascendia Pharmaceutical Solutions for:
Posted Date: 12/1/2024
This record has been viewed 17687 times.
Fill out the form and submit today
